Ocular Oncology and Pathology

Scope & Guideline

Connecting Researchers for a Brighter Vision

Introduction

Welcome to your portal for understanding Ocular Oncology and Pathology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2296-4681
PublisherKARGER
Support Open AccessNo
CountrySwitzerland
TypeJournal
Convergefrom 2015 to 2024
AbbreviationOCUL ONCOL PATHOL / Ocul. Oncol. Pathol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND

Aims and Scopes

The journal 'Ocular Oncology and Pathology' focuses on advancing knowledge in the field of ocular tumors and associated pathologies. It emphasizes a multidisciplinary approach that integrates clinical, pathological, and imaging methodologies to improve diagnosis, treatment, and understanding of ocular malignancies.
  1. Ocular Tumor Diagnosis and Management:
    The journal covers a wide range of ocular tumors, including uveal melanoma, retinoblastoma, and conjunctival melanoma, focusing on innovative diagnostic techniques and treatment modalities.
  2. Pathological Insights into Ocular Conditions:
    It provides insights into the histopathological features of various ocular tumors, enhancing the understanding of their biological behavior and potential therapeutic targets.
  3. Multimodal Imaging Techniques:
    Research on advanced imaging modalities such as optical coherence tomography and magnetic resonance imaging is emphasized, aiding in the accurate diagnosis and monitoring of ocular tumors.
  4. Therapeutic Innovations:
    The journal highlights new treatment approaches, including brachytherapy, stereotactic radiosurgery, and chemotherapy, aiming to improve patient outcomes and minimize side effects.
  5. Epidemiological and Clinical Studies:
    It publishes studies on the epidemiology, clinical outcomes, and quality of life related to ocular malignancies, contributing to a comprehensive understanding of these diseases.
Recent publications in 'Ocular Oncology and Pathology' reveal several emerging themes that reflect the evolving landscape of ocular oncology research. These trends indicate a shift towards more personalized and precise approaches in the management of ocular tumors.
  1. Targeted Therapies and Personalized Medicine:
    There is an increasing focus on targeted therapies and personalized medicine, particularly in the context of uveal melanoma and retinoblastoma, as researchers seek to tailor treatments based on individual tumor characteristics.
  2. Integration of Genomic and Molecular Data:
    The incorporation of genomic and molecular studies into ocular oncology is on the rise, highlighting the importance of genetic profiling in predicting outcomes and guiding treatment strategies.
  3. Longitudinal Studies on Treatment Outcomes:
    Emerging themes include the need for longitudinal studies that assess long-term outcomes of various treatment modalities, reflecting a growing interest in survivorship and quality of life post-treatment.
  4. Multidisciplinary Approaches to Ocular Tumors:
    There is a notable trend towards multidisciplinary approaches, combining insights from oncology, pathology, radiology, and surgery to improve comprehensive care for patients with ocular tumors.
  5. Exploration of Immunotherapy:
    Research on the role of immunotherapy in the treatment of ocular malignancies is gaining prominence, as there is an increasing interest in harnessing the immune system to combat these cancers.

Declining or Waning

While the journal continues to thrive in several key areas, certain themes appear to be declining in prominence over time. This shift may reflect advancements in treatment and changes in research focus within the field.
  1. Traditional Chemotherapy for Ocular Tumors:
    There is a noticeable decrease in research focusing solely on traditional chemotherapy approaches for ocular tumors, as newer targeted therapies and immunotherapies gain traction in clinical practice.
  2. Non-Invasive Diagnostic Techniques:
    Although still relevant, the emphasis on less invasive diagnostic techniques has diminished, possibly due to the increasing sophistication and accuracy of imaging technologies.
  3. Histopathological Correlation without Clinical Context:
    Research that exclusively discusses histopathological findings without correlating them to clinical outcomes is becoming less common, as there is a growing demand for studies that integrate clinical and pathological data.

Similar Journals

Case Reports in Ophthalmology

Exploring unique case studies for better vision.
Publisher: KARGERISSN: 1663-2699Frequency: 3 issues/year

Case Reports in Ophthalmology is an esteemed peer-reviewed journal published by KARGER, dedicated to advancing the field of ophthalmology through the dissemination of high-quality case reports. Since its establishment in 2010, the journal has maintained its Open Access model, ensuring that valuable research is accessible to a global audience, thus fostering collaboration and innovation in eye care. Hailing from Switzerland, the journal covers a broad range of topics within ophthalmology, providing a platform for clinicians and researchers to share unique clinical insights and pivotal findings. With a current impact factor that positions it within the Q3 category of ophthalmology in the 2023 rankings, Case Reports in Ophthalmology is a vital resource for professionals seeking to stay abreast of emerging trends and case studies in the field. Researchers and students alike will benefit from its rigorous peer-review process and its commitment to supporting quality research initiatives, making it an essential addition to any ophthalmology library.

Eye and Vision

Pioneering insights in the realm of eye and vision health.
Publisher: BMCISSN: 2326-0246Frequency: 1 issue/year

Eye and Vision, published by BMC, is a leading open-access journal dedicated to the dynamic field of ophthalmology and visual sciences. With its ISSN 2326-0246 and E-ISSN 2326-0254, the journal has established itself as a premier platform for innovative research and clinical studies, achieving impressive rankings in 2023 as Q1 in both Health Professions (Miscellaneous) and Ophthalmology categories. The journal's commitment to accessible knowledge since its transition to open access in 2015 enhances its global reach, allowing researchers, clinicians, and students to share and access top-tier studies and advancements in the field. Located in the United Kingdom and delivering influential insights from 2014 through to 2024, Eye and Vision holds significant relevance, with a Scopus ranking placing it in the 99th percentile for Health Professions and the 93rd percentile for Ophthalmology, making it an essential resource for those looking to stay at the forefront of eye research and vision science.

OPHTHALMIC RESEARCH

Elevating Standards in Ophthalmic Research and Practice
Publisher: KARGERISSN: 0030-3747Frequency: 6 issues/year

Ophthalmic Research, with ISSN 0030-3747 and E-ISSN 1423-0259, is a distinguished peer-reviewed journal published by Karger in Switzerland. Established in 1970, this journal serves as a vital resource for exploration and dissemination of knowledge within the fields of Ophthalmology, Cellular and Molecular Neuroscience, and Sensory Systems, maintaining its relevance through its convergence into modern research methodologies leading up to 2024. With impressive rankings in 2023, it holds a Q2 quartile in both Ophthalmology and Medicine (miscellaneous), reflecting its significant contribution to the academic community, alongside Scopus ranks that position it favorably in the competitive landscape of medical and neuroscientific literature. Although not open access, the journal ensures that high-quality research remains accessible to its readership, which includes researchers, professionals, and students eager to stay at the forefront of ophthalmic advancements. By fostering interdisciplinary collaboration and facilitating high-level discourse, Ophthalmic Research is pivotal for those committed to advancing the future of eye care and vision sciences.

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE

Connecting research and practice for better eye health.
Publisher: CANADIAN OPHTHAL SOCISSN: 0008-4182Frequency: 6 issues/year

Canadian Journal of Ophthalmology - Journal Canadien d'Ophtalmologie, published by the prestigious Canadian Ophthalmological Society, serves as a leading platform for disseminating cutting-edge research in the field of ophthalmology. With an ISSN of 0008-4182 and E-ISSN 1715-3360, the journal boasts a commendable impact factor and maintains a strong presence within the medicine and ophthalmology categories, ranking in the Q2 quartile. This journal not only provides significant insights into clinical practices and advancements but also contributes to the understanding of ocular health issues facing contemporary society. Since its inception in 1966, it has published high-quality research, making substantial strides in both practical and theoretical aspects of ophthalmology until 2024. Although it is not an open-access journal, it establishes a vital resource for researchers, professionals, and students alike, fostering an informed community dedicated to improving vision care.

JOURNAL FRANCAIS D OPHTALMOLOGIE

Connecting professionals to the latest in vision care advancements.
Publisher: MASSON EDITEURISSN: 0181-5512Frequency: 10 issues/year

JOURNAL FRANCAIS D OPHTALMOLOGIE, published by MASSON EDITEUR, is a prominent peer-reviewed journal that serves as a vital resource in the field of ophthalmology. Launched in 1978, this esteemed publication continues to make significant contributions to the advancement of ocular health and vision science, with its scope encompassing clinical practices, innovative research, and the latest technological advancements in ophthalmic care. Based in France, the journal is recognized in the 2023 category quartiles with a Q3 ranking in ophthalmology, reflecting its dedication to quality scholarship within a competitive landscape, as evidenced by its positioning in the 30th percentile of the Scopus rankings. While it operates without Open Access, the journal remains crucial for professionals, researchers, and students alike, providing a platform for sharing knowledge and fostering collaborations in the global ophthalmological community.

Eye & Contact Lens-Science and Clinical Practice

Empowering professionals with essential eye care knowledge.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1542-2321Frequency: 6 issues/year

Eye & Contact Lens-Science and Clinical Practice, published by Lippincott Williams & Wilkins, stands as a premier journal in the fields of ophthalmology and contact lens research. With an ISSN of 1542-2321 and an E-ISSN of 1542-233X, this journal serves as a vital resource for researchers, clinicians, and students dedicated to the study and application of eye care practices. Maintaining a distinguished impact factor within the Q2 category of Medicine and Ophthalmology as of 2023, it ranks impressively at #33 among 137 journals, placing it in the top 76th percentile according to Scopus metrics. Since its inception in 1986, Eye & Contact Lens has consistently delivered cutting-edge research and clinical insights, facilitating advancements in therapeutic techniques for contact lens wear and ocular health. Though not an Open Access journal, it remains accessible through institutional subscriptions, ensuring that essential findings are shared among professionals in the field. The objective of the journal is to present high-quality, peer-reviewed articles that advance the science and practice of eye care, making it an indispensable tool for those seeking to enhance their knowledge and contribute to this dynamic discipline.

Asia-Pacific Journal of Ophthalmology

Leading the charge in ophthalmic advancements.
Publisher: ASIA-PACIFIC ACAD OPHTHALMOLOGY-APAOISSN: Frequency: 6 issues/year

Asia-Pacific Journal of Ophthalmology is a distinguished open access journal published by the Asia-Pacific Academy of Ophthalmology (APAO), specializing in the latest advancements and research in ophthalmology. Since its inception in 2013, this journal has established itself as a vital platform for disseminating innovative findings and clinical practices across the Asia-Pacific region and beyond. With an impressive Scopus ranking of #10 out of 137 in the field of Medicine (Ophthalmology), placing it in the 93rd percentile, it garners significant attention and respect within the academic community. Currently holding a Q1 categorization in both Medicine (miscellaneous) and Ophthalmology, the journal embraces a broad scope that encompasses clinical studies, experimental research, and reviews aimed at enhancing the understanding and management of eye health. Its open access model since 2019 ensures that all published works are freely accessible, promoting greater collaboration and knowledge sharing among researchers, clinicians, and students. Situated in the Netherlands with a prominent address in Hong Kong, the journal serves as an essential resource for anyone dedicated to the field of ophthalmology.

Ocular Surface

Elevating Knowledge in Ocular Surface Science
Publisher: ELSEVIERISSN: 1542-0124Frequency: 4 issues/year

Ocular Surface, published by Elsevier, stands at the forefront of ophthalmology research, with a notable Impact Factor reflecting its significant contribution to the field. As a vibrant platform for disseminating cutting-edge findings, this journal has achieved Q1 ranking in the Ophthalmology category as of 2023, placing it amongst the top-tier journals globally, specifically ranking 4th out of 137 in Scopus with an impressive 97th percentile. Spanning across the years from 2003 to 2024, Ocular Surface focuses on advancing knowledge in areas such as ocular pathology, therapy, and surgical interventions. While the journal is not open access, it provides invaluable insights and empirical data essential for researchers, professionals, and students dedicated to improving ocular health. With an address rooted in Amsterdam, Netherlands, this esteemed journal continues to enrich the global conversation in ophthalmology.

OPHTHALMOLOGICA

Inspiring Progress in Ophthalmic Research
Publisher: KARGERISSN: 0030-3755Frequency: 6 issues/year

OPHTHALMOLOGICA is a prestigious journal published by KARGER, dedicated to the dynamic field of ophthalmology and its interdisciplinary connections with medicine and sensory systems. With a rich history spanning over a century since its inception in 1899, this journal is esteemed for its high-quality research and impactful contributions, maintaining an impressive Q1 quartile ranking in both ophthalmology and miscellaneous medicine as of 2023, alongside a notable Q2 status in sensory systems. The journal's influence is reinforced by its Scopus rankings, where it ranks 26th out of 137 in ophthalmology, showcasing a strong percentile position of 81. Based in Basel, Switzerland, OPHTHALMOLOGICA serves as an essential platform for researchers, professionals, and students, providing essential insights, reviews, and studies that push the boundaries of knowledge in the vision sciences. Although it does not currently offer open access, its contributions are critical for those pursuing advancements in ocular health and related disciplines.

EUROPEAN JOURNAL OF OPHTHALMOLOGY

Elevating Knowledge in Ophthalmology for Better Outcomes
Publisher: SAGE PUBLICATIONS LTDISSN: 1120-6721Frequency: 6 issues/year

The EUROPEAN JOURNAL OF OPHTHALMOLOGY, published by SAGE PUBLICATIONS LTD, is a leading international journal in the field of ophthalmology, dedicated to advancing the understanding and treatment of ocular diseases and disorders. With an ISSN of 1120-6721 and an E-ISSN of 1724-6016, the journal aims to provide a platform for innovative research, critical reviews, and comprehensive studies that span the diverse aspects of the discipline. As part of its commitment to disseminating high-quality research, the journal is indexed in Scopus, achieving an impressive rank of #47 out of 137 in the Medicine - Ophthalmology category, indicating its strong impact within the academic community. With a current impact factor that places it in the Q2 quartile for both Medicine (miscellaneous) and Ophthalmology as of 2023, it offers researchers and practitioners access to important findings and developments in eye health. The journal's converged years from 1991 to 2024 exemplify its longstanding commitment to the field, making it an essential resource for anyone looking to stay at the forefront of ophthalmological research.